Regulatory Adoption Page

Regulatory Adoption in Drug Development Regulatory authorities worldwide trust Certara’s solutions for PK/PD modeling, biosimulation, and clinical data validation Learn more about Certara’s regulatory-grade solutions Contact us Meeting the highest...

Best Practices for Annotated CRFs Blog Post

In this webinar, Amy Garrett reviews published guidance from regulatory agencies and provides best practices for CRF annotations.

Salvaging CNS Clinical Trials Halted Due to COVID‐19 Blog Post

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical trials, especially in Alzheimer’s disease. These long‐duration trials involve many stakeholders, especially the patients and…

Rare and Neglected Diseases Page

By leveraging quantitative models, regulatory expertise, and real-world data, we empower our partners to fast-track innovative therapies while meeting stringent regulatory standards.

Pediatric Practice Page

Certara’s Pediatric MIDD Accelerator advances efficient and reliable pediatric drug development processes that optimize dosing and get critical medicines to children faster.

Upcoming Simcyp Workshops Page

Upcoming Simcyp™ Workshops What are the benefits of the Simcyp week-long workshops? Participants will learn about the application of “prior knowledge” to improve the selection and design of clinical studies....